Royce & Associates’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,000
| Closed | -$94K | – | 838 |
|
|
2024
Q3 | $94K | Hold |
50,000
| – | – | ﹤0.01% | 846 |
|
|
2024
Q2 | $370K | Hold |
50,000
| – | – | ﹤0.01% | 810 |
|
|
2024
Q1 | $392K | Hold |
50,000
| – | – | ﹤0.01% | 805 |
|
|
2023
Q4 | $254K | Hold |
50,000
| – | – | ﹤0.01% | 831 |
|
|
2023
Q3 | $296K | Hold |
50,000
| – | – | ﹤0.01% | 850 |
|
|
2023
Q2 | $371K | Hold |
50,000
| – | – | ﹤0.01% | 859 |
|
|
2023
Q1 | $473K | Buy |
+50,000
| New | +$473K | ﹤0.01% | 843 |
|